Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001725160-25-000161
Filing Date
2025-11-10
Accepted
2025-11-10 16:15:23
Documents
75
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zntl-20250930.htm   iXBRL 10-Q 1536247
2 EX-10.1 zentalis-q3xex101apaulrele.htm EX-10.1 108945
3 EX-31.1 zentalis10-qq32025ex311.htm EX-31.1 10705
4 EX-31.2 zentalis10-qq32025ex312.htm EX-31.2 10950
5 EX-32.1 zentalis10-qq32025ex321.htm EX-32.1 5558
6 EX-32.2 zentalis10-qq32025ex322.htm EX-32.2 5419
12 image_4a.jpg GRAPHIC 858
  Complete submission text file 0001725160-25-000161.txt   6988150

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zntl-20250930.xsd EX-101.SCH 39605
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zntl-20250930_cal.xml EX-101.CAL 77879
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zntl-20250930_def.xml EX-101.DEF 190781
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zntl-20250930_lab.xml EX-101.LAB 567905
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zntl-20250930_pre.xml EX-101.PRE 399638
77 EXTRACTED XBRL INSTANCE DOCUMENT zntl-20250930_htm.xml XML 870368
Mailing Address 10275 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 10275 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121 (858) 263-4333
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

EIN.: 823607803 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39263 | Film No.: 251466400
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)